MS Oral Therapy

Fingolimod

Prescription capsule to reduce relapse rates and delay disability progression in multiple sclerosis.

Fingolimod is an oral immunomodulating medication used to treat relapsing forms of multiple sclerosis (MS). It works by retaining certain white blood cells (lymphocytes) in lymph nodes, preventing them from attacking the nervous system. This reduces inflammation, slows disease progression, and helps prevent relapses that cause neurological impairment. Fingolimod offers an effective daily oral treatment option for MS patients who require disease-modifying therapy to maintain mobility and quality of life.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers

  • Reduces annualized relapse rates in relapsing-remitting multiple sclerosis by up to 54% versus placebo

  • Slows disability progression and reduces MRI lesion activity, indicating suppression of underlying disease activity

  • Provides sustained benefits with continued daily use for long-term management of MS symptoms and disease course

  • Offers an oral alternative to injectable therapies, improving treatment adherence and convenience

  • Fingolimod: A sphingosine 1-phosphate receptor modulator that prevents lymphocytes from exiting lymph nodes, reducing their migration into the central nervous system to decrease inflammation and demyelination

  • Take one 0.5mg capsule by mouth once daily, with or without food

  • Do not crush, chew, or open the capsule

  • The first dose should be administered under medical supervision with heart rate monitoring for at least 6 hours

  • Continue daily dosing as prescribed; missing doses may require re-initiation of monitoring

  • Routine blood tests and ophthalmic exams are recommended to monitor for side effects